Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...
FAYETTEVILLE, GA, UNITED STATES, January 15, 2026 /EINPresswire.com/ -- Understanding why cancer cells rely on specific ...
The GOG 3026 trial demonstrated that ribociclib and letrozole combination therapy achieved a 31% response rate and 84% ...
Combination therapies represent a promising frontier in cancer treatment, addressing the critical need to enhance efficacy while minimizing resistance. By combining different therapeutic agents and ...
New recommendations prioritise multiparametric MRI, safer transperineal biopsy, and earlier escalation for high-risk prostate ...
A hidden communication network between brain cells and glioblastoma tumors may be key to slowing this aggressive cancer.
This article summarizes metabolic reprogramming in prostate cancer (PCa). Early PCa relies more on glycolysis.
"My prognosis was so good because I was seen so quickly," she told BBC News NI. She said recent scans indicated that she was "cancer free" at the minute, and she "definitely" attributes that "to the ...
The U.S. Food and Drug Administration (FDA) has accepted a new drug application for gedatolisib in hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-), PIK3CA ...
The FDA granted orphan drug designation to zavabresib, an investigational therapy for the treatment of myelofibrosis, a rare ...
Scientists from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) have identified why certain lung cancer cells become highly resistant to treatment after developing mutations in a key gene ...
HHMI Investigator Kevan Shokat and his lab are charting new therapies to outmaneuver drug resistance and better target common cancer cell mutations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results